Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Corning, Promega, Cold Spring Harbor Laboratory Press

Premium

Invitrogen announced that it has introduced the Block-iT RNAi family of products, which include custom synthetic siRNAs, a Dicer system, a transfection kit, and a transcription kit.

“We have seen the impact that RNAi is making and have responded,” Claude Benchimol, senior vice president of R&D at Invitrogen, said in a statement. “We will continue to provide innovative additions to the Block-iT platform.”


Corning and Promega said this week that they have agreed to jointly develop, manufacture, and commercialize a system of reagents for self-printing microarrays.

The integrated system of slides and reagents, called Pronto! Plus, will join Corning’s Pronto! microarray reagent system with Promega’s SV Total RNA isolation system, ChipShot labeling system, and ChipShot labeling cleanup system.

“The…Pronto! Plus systems optimize input RNA quality, labeling efficiency, and hybridization background, giving a new level of sensitivity, reproducibility, and success in DNA microarrays,” Pierce Baker, senior vice president of Corning Life Sciences, said in
a statement.


Cold Spring Harbor Laboratory Press has released a new book, entitled RNAi: A Guide to Gene Silencing.

Edited by CSHL researcher Greg Hannon, the work includes chapters covering topics such as sense cosuppression in plants, RNAi in C. elegans, and RdRp in gene silencing, by authors including Richard Jorgensen of the University of Arizona, Rene Ketting of the Hubrecht Laboratory, and Luyun Huang of Penn State.

The book is available directly through CSHL Press’ website (www.cshlpress.com) and costs $130, hardcover.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.